is tirzepatide or semaglutide more effective for weight loss vs. Semaglutide: Which Best Loss? Semaglutide vs. Tirzepatide for Weight

Approximately 25% of Tirzepatide patients experience nausea compared to 44% taking Semaglutide

The SURMOUNT-5 trial changed everything by directly comparing these medications in the same study

Which One Is Right for You

You have established cardiovascular disease (proven MACE reduction) Insurance covers Wegovy but not Zepbound You are already responding well to Semaglutide treatment Longer real-world safety data provides peace of mind Oral medication option (Rybelsus) is preferred Semaglutide remains the evidence-based choice for patients with established cardiovascular disease

If medications stop producing benefit, or if side effects become problematic, discontinuation with careful monitoring makes sense